Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)

NCT02268253

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • University of California, San Francisco Clovis, California, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 24 locations
View Trial Details
Completed

IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

NCT04522895

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany
  • Uniklinik RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Aachen, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Germany
View Trial Details
Completed

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

NCT03814005

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +22 more
Locations
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • ICO lHospitalet Hospital Duran i Reynals LHospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
View Trial Details
Completed

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

NCT02907359

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Cancer Specialists of North Florida Fleming Island, Florida, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
View all 112 locations
View Trial Details
Completed

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

NCT03306264

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Compassionate Cancer Care Research Group Fountain Valley, California, United States
View all 84 locations
View Trial Details
Completed

Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

NCT00043381

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Scripps Clinic Escondido, California, United States
  • Loma Linda Univ. Cancer Center Loma Linda, California, United States
View all 24 locations
View Trial Details
Completed

Effect of Food on Blood Levels of ASTX727

NCT03813186

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Roswell Park Buffalo, New York, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Vanderbilt Nashville, Tennessee, United States
  • Mays Cancer Center UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas, United States
View Trial Details
Completed

Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia

NCT02807272

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

NCT03493646

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View Trial Details

Related conditions